StockDuty ← Dashboard Oct 21, 2026 10:58 AM ET
SignalEarnings

Thermo Fisher posts Q3 beat as lab products unit outperforms

Q3 beat driven by lab products unit outperformance.

Context
What happened: Thermo Fisher Scientific (TMO) rose in premarket trading after reporting better-than-expected Q3 2026 financials, led by its Laboratory Products and Biopharma Services unit. Key numbers: Revenue was $12.1B for the quarter. Why it matters: The beat was attributed mainly to the Laboratory Products and Biopharma Services unit, and shares gained in premarket trading.
What changed
Thermo Fisher Scientific (TMO) rose in premarket trading after reporting better-than-expected Q3 2026 financials, led by its Laboratory Products and Biopharma Services unit.
Why it matters
The beat was attributed mainly to the Laboratory Products and Biopharma Services unit, and shares gained in premarket trading.
Sources
seekingalpha
Related signals
SAMSUNG SDI POSTS EARNINGS SURPRISE , RETURNS TO PROFIT AFTER 7 QUARTERS →INDIA ECONOMIC GROWTH RATE COULD BE CLOSER TO 7 %, BEAT ESTIMATES : RBI POONAM GUPTA →MCDONALD'S EARNINGS BEAT ESTIMATES, CHAIN ANNOUNCES NEW U.S. HEAD TO ACCELERATE GROWTH - CNBC →